Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.

@article{Nomura2006CosteffectivenessAO,
  title={Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.},
  author={K Nomura and K Kawasugi and T Morimoto},
  journal={European journal of cancer care},
  year={2006},
  volume={15 1},
  pages={44-50}
}
  • K Nomura, K Kawasugi, T Morimoto
  • Published 2006 in European journal of cancer care
Invasive fungal infections are fatal complications for patients on chemotherapy, and antifungal prophylactic treatment has been commonly recommended. Because its clinical and economic impact is not well known, we evaluated cost-effectiveness of anti-fungal treatment for patients who were neutropoenic as a result of chemotherapy. We constructed a hypothetical cohort of 40-year-old patients with acute myelogenic leukemia to evaluate years of life survived (YLS), costs (US$), and incremental cost… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-3 of 3 references

Meta - analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia

  • PC Gotzsche, HK Johansen
  • BMJ
  • 1997

Similar Papers

Loading similar papers…